Biotech Values

[DewDiligence]

At least get two extra weeks of exclusivity...

Every day of exclusivity helps, of course, but the more bullish aspect of today’s action is that the Judge did not dismiss MNTA’s suit out of hand, but rather suggested a willingness to consider MNTA’s request for limited expedited discovery.

There’s a still a lot of work to be done but so far, so good.